S9 Ep27: Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

from OncLive® On Air · host OncLive® On Air

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

Episode metadata supplied by the publisher feed · Published Sep 18, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S9 Ep27: Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0:00 21:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 21 minutes long.

When was this OncLive® On Air episode published?

This episode was published on September 18, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!